Interference 102,760
a method for treatment of sleep apnea comprising
administration of a therapeutically effective amount of
buspirone to a patient in need of such treatment . . . . The
date when such contribution was made was prior to April, 1986.
. . .” (SRR, WIA, RI 2,
p. 258).
E. “Dement and . . . Rosekind conceived of at least a
specific dosage of buspirone to be given to patients having
sleep apnea at bedtime, i.e., 20 milligrams of buspirone. The
date of this conception was prior to August 9, 1989. . . .”
(SRR, WIA,
RI 2, p. 259).
F. “For all claims in which . . . Rosekind is
identified as an inventor in response to Interrogatory No. 1
[(RI 1)], his contribution to the conception of the invention
was his concept, along with Dr. Dement of at least a specific
dosage of buspirone to be given to patients having sleep apnea
at bedtime, i.e.,
20 milligrams of buspirone. The date of this conception was
prior to August 9, 1989. . . .” (SRR, WIA, RI 3, p. 260).
G. “As to . . . claims 1, 2, 6, 7 and 13 of application
Serial No. 07/695,325, the contribution of . . . Schwimmer to
12
Page: Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next
Last modified: November 3, 2007